Gara Jalqabaatti › Edema Makulaarii
Qorannoo klinikaalii Edema Makulaarii Ameerikaa Keessatti hirmaatuu
Qorannoo 8 Edema Makulaarii f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Austin, TXQorannoo 4
- San Antonio, TXQorannoo 4
- Hagerstown, MDQorannoo 4
- Raleigh, NCQorannoo 4
- Glendale, CAQorannoo 3
- Denver, COQorannoo 3
- Houston, TXQorannoo 3
- Columbia, SCQorannoo 3
- Sacramento, CAQorannoo 3
- Boston, MAQorannoo 3
- Cypress, TXQorannoo 3
- Fort Lauderdale, FLQorannoo 3
- The Woodlands, TXQorannoo 3
- Phoenix, AZQorannoo 3
- Cleveland, OHQorannoo 3
- Pasadena, CAQorannoo 3
- Nashville, TNQorannoo 3
- Carmel, INQorannoo 3
- Eugene, ORQorannoo 3
- Charleston, SCQorannoo 3
Naannoon
- ArizonaQorannoo 3
- CaliforniaQorannoo 4
- ColoradoQorannoo 4
- ConnecticutQorannoo 3
- FloridaQorannoo 5
- IndianaQorannoo 3
- MarylandQorannoo 4
- MassachusettsQorannoo 3
- New JerseyQorannoo 3
- New YorkQorannoo 3
- North CarolinaQorannoo 6
- OhioQorannoo 3
- OregonQorannoo 3
- PennsylvaniaQorannoo 3
- South CarolinaQorannoo 5
- TennesseeQorannoo 4
- TexasQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07705607A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06962839Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 05-Wax-2026 · NCT06395285A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT06996080Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 26-Sad-2025 · NCT04225611Imaging Retinal Vasculature in Infant Eyes
Namoota walitti qabaa jiraQorannoo ilaalaa
2 Months · Saalaa hunda · Haaromfame 06-Onk-2025 · NCT05558059Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.